MMF unlocks a new path to venetoclax sensitivity in AML
Abstract
biomarkers of treatment response could further refine patient stratification and help identifying patients with refractory disease who might benefit from rapid therapeutic escalation.
Fields of Study & Subjects
Acute Myeloid Leukemia Research
Chronic Lymphocytic Leukemia Research
Retinoids in leukemia and cellular processes
Publication details
- Journal / source
- Blood
- Volume
- 147
- Issue
- 7
- Pages
- 708–709
- Publication date
- 12 February 2026
- Language
- EN